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ABSTRACT  
Objective: To determine the prevalence of transfusion 
transmitted diseases like viral hepatitis B and C in 
thalassaemic patients.  
Study Design: Descriptive / cross section study  
Place and Duration of Study: The study was carried out 
from Jan 2018 to Mar 2018 at the Paediatrics 
Department, Sheikh Khalifa Bin Zayed Teaching 
Hospital, Rawalakot, AJK Teaching Hospital of Poonch 
Medical College, Rawalakot.  
Materials and Methods:There were 55 patients of 
thalassaemic who were screened for transfusion 
transmitted hepatitis B & C virus with the use of electro 
chemiluminescenceauto analyserelecsysCobas E 411 and 
where possible PCR techniques. The result i.e., infection 
of hepatitis B & C was stratified by age, equality and 
duration of transfusion.  
Results: There was 30/91% prevalence of transfusion 
transmitted hepatitis C in the current research and it had 
a statistically significant association with the age and 
duration of blood transfusion in thalassaemic 
patients.None of the patient had positive Hepatitis B.  
Conclusion: High prevalence of transfusion transmitted 
hepatitis C in thalassaemic patients notwithstanding 
adoption of donor blood screening protocols requires to 
be addressed on urgent basis for the determination of 
elements causing this transfusion therapy complication.  
Key Words: Chelation,Cirrhosis liver, Hepatitis 
C,Transfusion,Thalassemia,Viral Hepatitis 
INTRODUCTION  
Thalassaemia, an autosomal recessive disorder, 
significant reason for serious anaemia in children 
and young adults. The thalassaemia prevalence is 
high specifically in geographically area spreading 
from South East Asia to Middle East causing 
effects to Burma and Sub-continent of India too. 
The prevalence of thalassaemia disease is very high 
in Pakistan and as per recent estimation, 5000 
infants every year homozygous for thalassaemia 
are born. The patients of thalassaemia are 
dependenton regular transfusion of blood during 
whole life to survive and although the regular 
transfusion of blood makes good the thalassaemic 
patient’s survival overall, they are vulnerable 
tosignificant transfusion risk connected with 
infection specifically bloodborne viral infection. 
In case of dearth of research and data from this part 
and a big variation reported hepatitis C prevalence 
in the patients of thalassaemia from Pakistan, it has 
been decided for the determination of viral hepatitis 
B&C prevalence and the risk elements connected 
with the hepatitis C transmission in the patients of 
thalassaemia enrolled with the department. It has 
been considered that theoutcome information may 
be utilised for the revision of the prevailing 
strategies of management in place. 
MATERIALS AND METHODS  
This descriptive cross-sectional study was carried 
out from Nov 2016 to May 2017 at the Paediatrics 
Department, Sheikh Khalifa Bin Zayed Teaching 
Hospital, Rawalakot AJK (Teaching Hospital of 
Poonch Medical College, Rawalakot.There were 55 
patients of thalassaemic participated in the study 
and thereafter written consent was obtained from 
them. Minimum 2years ofage thalassaemia patient 
who have undergone the transfusion were made 
part of this research. The patients were receiving 
chelation therapy in the centre and regular 
transfusion of blood as well. 3 CC blood was taken 
from the patient’s antecubital vein under tight 
aseptic condition and was forwarded to laboratory 
for HbsAg and antibody levels by electro 
chemiluminescenceauto analyser elecsysCobas E 
411. The patient screened by device method for 
positive anti HCV they were again contacted and 
again blood was taken to assess the level of HCV 
viral DNA both for qualitative and quantitative 
polymerase chain reactions. The patients confirmed 
by PCR for positive HCV were referred to 
gastroenterologist for future management. The 
examiners recorded the data. SPSS Version 16 was 
used for analysing the data. Calculation of 
meal+SD for numerical variableswhereas the 
calculation of percentage and frequency was for 
categorical variables. The result of hepatitis C 
infection was segregated by parity, age and 
transfusion duration. Chi square test was used after 
segregation and value of P<0.05 was taken to be 
significant.  
RESULTS  
The research was comprised of 55 patients of 
thalassaemic with a mean±SD age of 9.16±6.36 
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years and between the age of 3 to 30 years. The 
transfusion mean duration was 8.02±5.45 years. 
The study group was having male were 30(54.55%) 
and females were 25(45.45%).Initially the positive 
hepatitis C frequency was 41.82%(n=23) but later 
it went down to 30.91%(n=17) after PCR 
examines. Positive HbsAg was not found in any 
patient.A statistically significant connection was 
found with the patients’ age and duration of 
transfusion (p<0.05) when the findings i.e., 
hepatitis C was classified by parity, age and 
duration of transfusion. Chronis patients of 
thalassaemia were prone to catch hepatitis C. 
Likewise, patients having long blood transfusion 
duration (over 9 years) were prone to risk of 
catching hepatitis C. 
DISCUSSION  
The purpose of the current study is the 
determination of HbsAg and anti HCV antibodies 
prevalence in the patients of thalassaemia from 
Rawalakot, AJK. In the research the man form of 
thalassaemia is theβ-thalassemia and it was found 
in 96.3% patients. The remaining patients had β-
thalassemia intermedia. Similar rate of prevalence 
has been found in the current region : 4& and 96% 
for β-thalassemia intermedia and β-thalassemia 
major respectively from Rawalpindi, 7% and 93% 
β-thalassemia intermedia and β-thalassemia major 
respectively from Faisalabad and 13% and 87% β-
thalassemia intermedia and β-thalassemia major 
respectively from India. The hepatitis C prevalence 
was found by the study as 30.91% though it is high, 
but it is likewise with other reports from other parts 
of Pakistan. Mostly patients of the current research 
are male (n=30; 54.55%), the affected females are 
twice in number than the male effected (11 V 6).  
Although in Pakistan the blood transfusion 
screening procedure is being adopted and is in 
place for decades, but the hepatitis C high 
prevalence in the patients of multi transfused 
thalassaemia is upsetting scenario. The 
complication for transfusion therapy for the 
patients of thalassaemia is serious in nature and 
requires to be addressed on urgently basis. 
Planning and implementation of public health 
policy must focus on this issue and guideline 
requires to be drawn for the β-
thalassemiamanagement in Pakistanwhich must 
also deal with the prevention in population for 
blood borne infection. 
CONCLUSION 
High prevalence of transfusion transmitted hepatitis 
C in thalassaemic patients notwithstanding 
adoption of donor blood screening protocols 
requires to be addressed on urgent basis for the 
determination of elements causing this transfusion 
therapy complication. 
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